Inventor · disambiguated record
Sreenivas S. Bhat
Also filed as: BHAT SREENIVAS S
11 granted patents·5 pending applications·102 citations·filing 2011–2025
90Inventor score
Top patents by PatentIndex Score
16 records- 0188US9198866B2Pharmaceutical formulations of a substituted diaminopurineSIGNAL PHARM LLC·Filed 2013·Granted Dec 1, 2015·15 cites·18 claims
- 0285US8603527B2Pharmaceutical formulations of a substituted diaminopurineBHAT SREENIVAS S·Filed 2011·Granted Dec 10, 2013·18 cites·18 claims
- 0378US11389454B2Tablet compositionsCELGENE CORP·Filed 2017·Granted Jul 19, 2022·2 cites·4 claims
- 0476US2024335450A1Tablet compositionsCELGENE CORP·Filed 2024·Application pending·0 cites
- 0573US12220417B2Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and methods of using the sameCELGENE CORP·Filed 2022·Granted Feb 11, 2025·0 cites·20 claims
- 0670USD835258SPharmaceutical tabletCELGENE CORP·Filed 2018·Granted Dec 4, 2018·11 cites·1 claims
- 0769USD787042SPharmaceutical tabletCELGENE CORP·Filed 2015·Granted May 16, 2017·14 cites·1 claims
- 0869US2022323447A1Tablet compositionsCELGENE CORP·Filed 2022·Application pending·0 cites
- 0968USD787043SPharmaceutical tabletCELGENE CORP·Filed 2015·Granted May 16, 2017·13 cites·1 claims
- 1067USD858741SPharmaceutical tabletCELGENE CORP·Filed 2018·Granted Sep 3, 2019·9 cites·1 claims
- 1167USD835257SPharmaceutical tabletCELGENE CORP·Filed 2017·Granted Dec 4, 2018·10 cites·1 claims
- 1267USD813372SPharmaceutical tabletCELGENE CORP·Filed 2017·Granted Mar 20, 2018·10 cites·1 claims
- 1366US11504378B2Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and methods of using the sameCELGENE CORP·Filed 2020·Granted Nov 22, 2022·0 cites·42 claims
- 1460US2025144108A1Pharmaceutical compositions comprising (s)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and methods of using the sameCELGENE CORP·Filed 2025·Application pending·0 cites
- 1549US2013164376A1Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetylaminoisoindoline-1,3-dioneCELGENE CORP·Filed 2012·Application pending·0 cites
- 1638US2015196562A1Formulations of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dioneCELGENE CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sreenivas S. Bhat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →